Athyrium Opportunities III Acquisition 2 LP 13D and 13G filings for Amryt Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-18 4:15 pm Sale |
2023-04-12 | 13G | Amryt Pharma plc AMYT |
Athyrium Opportunities III Acquisition 2 LP | 0 0.000% |
-44,286,346 (Position Closed) |
Filing |
| 2021-02-12 08:01 am Purchase |
2020-07-08 | 13G | Amryt Pharma plc AMYT |
Athyrium Opportunities III Acquisition 2 LP | 44,286,346 24.800% |
44,286,346 (New Position) |
Filing |